A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
9/25/2026
BreakingDealsMyopiaRegulation
FDA Panel Meeting for Sydnexis’ Rejected Myopia Drop Candidate Set for Oct. 30
Sydnexis reported Sept. 24 that the US FDA had set Oct. 30 as the date for an advisory committee and open public hearing to review the new drug application (NDA) for SYD-101, an atropine eye drop c...
9/25/2026
BreakingCataractIOLRegulationSurgical
Rayner Launches RayOne Galaxy IOL in US after Receiving FDA Approval
UK-based Rayner announced Sept. 24 that its RayOne Galaxy and RayOne Galaxy Toric IOLs were commercially available in the US after the lenses gained FDA approval. The company noted that US surgeons...
9/25/2026
BreakingEuropeRegulationRetina
Roche Gains EU Approval for Susvimo Sustained-Release Wet AMD Treatment
Swiss drugmaker Roche announced Sept. 21 that the European Commission had granted marketing authorization for Susvimo (ranibizumab injection) 100 mg/mL for the treatment of wet age-related macular ...
9/22/2026
AIDiagnosticDigitalNewsletter
Future of Ophthalmic Diagnostic Innovation May Hinge on Integration, Reliability
Manufacturers have invested heavily in AI, cloud connectivity, and digital applications over the past several years. These developments are continuing, but AI and digitalization are becoming less d...
9/25/2026
BreakingDiagnosticFundusOCTRetina
Zeiss Introduces Alta Duo 300, a Fully Automated OCT Combination Retinal Imager
Zeiss Medical Technology reported Sept. 17 that it had introduced the Alta Duo 300 combination retinal imager. The device will be available in select markets later in 2026. The German company said ...
9/25/2026
BreakingDiagnosticFundusOCTRetina
Combination OCT-Fundus Camera Headlines Product Launches from Nidek
Japan’s Nidek announced Sept. 3 the launch of three new ophthalmic diagnostic offerings. The RSD-1 Duo, a combined OCT and fundus camera system, and the AFC-1 fundus camera increase efficiency acro...
9/25/2026
AllergyBreakingDry EyeRegulation
UK Pet Food Company Concludes Recall After Reports of Sudden Dry Eye Symptoms in Dogs
The Years pet food company, based in the UK, has concluded a recall of all its fresh pet food products after an independent investigation found no link between its ingredients and dog owners’ repor...
9/25/2026
BreakingPharmaRegulation
Bausch + Lomb Receives FDA Warning Letter for Tampa, Florida, Plant, Citing Persistent Contamination
The US FDA sent Bausch + Lomb a warning letter Sept. 4 regarding significant violations observed at its manufacturing plant in Tampa, Florida, during an FDA inspection in March 2026. The Tampa loca...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.